Manufacturer copay assistance · Darzalex (J9145) · Janssen (Johnson & Johnson)
$5/dose · Maximum benefit Up to $20,000/year · Covers drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Darzalex — the program's cap applies against the patient share CareCost calculates.
Yes — Janssen CarePath Savings Program from Janssen (Johnson & Johnson). $5/dose. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$5/dose Maximum benefit: Up to $20,000/year. Covers drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicaid, medicare, government.